Biological and pharmacological roles of N6-isopentenyladenosine: An emerging anticancer drug

Maurizio Bifulco, Anna M. Malfitano, Maria Chiara Proto, Antonietta Santoro, Maria Gabriella Caruso, Chiara Laezza

Research output: Contribution to journalArticle

Abstract

A common modification of eukaryotic and bacterial tRNAs is isopentenylation of the adenosine at position 37, with the formation of isopentenyladenosine. N6-Isopentenyladenosine plays a major role in posttranscriptional processes, including the function of mammalian selenocysteine tRNA. This molecule seems to have metabolic effects that, for its relationships with isoprenoid metabolism and its direct biological activities, affects mammalian cell cytoskeleton, proliferation and apoptosis. In addition, preliminary servation seems to indicate a possible use of N6-Isopentenyladenosine as anticancer drug.

Original languageEnglish
Pages (from-to)200-204
Number of pages5
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume8
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Isopentenyladenosine
Pharmacology
Pharmaceutical Preparations
Terpenes
Transfer RNA
Cytoskeleton
Adenosine
Cell Proliferation
Apoptosis

Keywords

  • N6-Isopentenyladenosine; apoptosis; cancer

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

Cite this

Biological and pharmacological roles of N6-isopentenyladenosine : An emerging anticancer drug. / Bifulco, Maurizio; Malfitano, Anna M.; Proto, Maria Chiara; Santoro, Antonietta; Caruso, Maria Gabriella; Laezza, Chiara.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 8, No. 2, 02.2008, p. 200-204.

Research output: Contribution to journalArticle

Bifulco, Maurizio ; Malfitano, Anna M. ; Proto, Maria Chiara ; Santoro, Antonietta ; Caruso, Maria Gabriella ; Laezza, Chiara. / Biological and pharmacological roles of N6-isopentenyladenosine : An emerging anticancer drug. In: Anti-Cancer Agents in Medicinal Chemistry. 2008 ; Vol. 8, No. 2. pp. 200-204.
@article{9fd208eafe5743508d8b9e6c04e28b11,
title = "Biological and pharmacological roles of N6-isopentenyladenosine: An emerging anticancer drug",
abstract = "A common modification of eukaryotic and bacterial tRNAs is isopentenylation of the adenosine at position 37, with the formation of isopentenyladenosine. N6-Isopentenyladenosine plays a major role in posttranscriptional processes, including the function of mammalian selenocysteine tRNA. This molecule seems to have metabolic effects that, for its relationships with isoprenoid metabolism and its direct biological activities, affects mammalian cell cytoskeleton, proliferation and apoptosis. In addition, preliminary servation seems to indicate a possible use of N6-Isopentenyladenosine as anticancer drug.",
keywords = "N6-Isopentenyladenosine; apoptosis; cancer",
author = "Maurizio Bifulco and Malfitano, {Anna M.} and Proto, {Maria Chiara} and Antonietta Santoro and Caruso, {Maria Gabriella} and Chiara Laezza",
year = "2008",
month = "2",
doi = "10.2174/187152008783497028",
language = "English",
volume = "8",
pages = "200--204",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Biological and pharmacological roles of N6-isopentenyladenosine

T2 - An emerging anticancer drug

AU - Bifulco, Maurizio

AU - Malfitano, Anna M.

AU - Proto, Maria Chiara

AU - Santoro, Antonietta

AU - Caruso, Maria Gabriella

AU - Laezza, Chiara

PY - 2008/2

Y1 - 2008/2

N2 - A common modification of eukaryotic and bacterial tRNAs is isopentenylation of the adenosine at position 37, with the formation of isopentenyladenosine. N6-Isopentenyladenosine plays a major role in posttranscriptional processes, including the function of mammalian selenocysteine tRNA. This molecule seems to have metabolic effects that, for its relationships with isoprenoid metabolism and its direct biological activities, affects mammalian cell cytoskeleton, proliferation and apoptosis. In addition, preliminary servation seems to indicate a possible use of N6-Isopentenyladenosine as anticancer drug.

AB - A common modification of eukaryotic and bacterial tRNAs is isopentenylation of the adenosine at position 37, with the formation of isopentenyladenosine. N6-Isopentenyladenosine plays a major role in posttranscriptional processes, including the function of mammalian selenocysteine tRNA. This molecule seems to have metabolic effects that, for its relationships with isoprenoid metabolism and its direct biological activities, affects mammalian cell cytoskeleton, proliferation and apoptosis. In addition, preliminary servation seems to indicate a possible use of N6-Isopentenyladenosine as anticancer drug.

KW - N6-Isopentenyladenosine; apoptosis; cancer

UR - http://www.scopus.com/inward/record.url?scp=41649111376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649111376&partnerID=8YFLogxK

U2 - 10.2174/187152008783497028

DO - 10.2174/187152008783497028

M3 - Article

C2 - 18288922

AN - SCOPUS:41649111376

VL - 8

SP - 200

EP - 204

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 2

ER -